4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0000899243-22-002025
Director bought 455,000 shares at an average $1.00 ($452,768)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC Director | 2022-01-12 | Purchase | +57,300 | $1.04 | $59,781 | 45,702,300 | I: show line 1 in the form |
| ARMISTICE CAPITAL, LLC Director | 2022-01-13 | Purchase | +312,700 | $1.00 | $314,013 | 46,015,000 | I: show line 2 in the form |
| ARMISTICE CAPITAL, LLC Director | 2022-01-14 | Purchase | +85,000 | $0.93 | $78,974 | 46,100,000 | I: show line 3 in the form |
| Open-market purchases · 455,000 sh · avg $1.00 · $452,768 | |||||||
Loading xslF345X03/doc4.xml…